Article may be outdated

This article is 46 days old. Some details may have changed since publication.

CancerNetwork·4 min read·hard

20 On the Upswing: A Retrospective Cohort Study Evaluating Neoadjuvant Chemotherapy Response in Metaplastic Breast Cancer Patients

J
Jessica F. Moore, Victoria Tiedemann, Julia Rozenberg, I. Angeles, Kamaljeet Singh, Stephanie Ng, Ashley R. Stuckey, Micaela A. Weaver, Jennifer Gass, William M. Sikov, MD, David A. Edmonson
20 On the Upswing: A Retrospective Cohort Study Evaluating Neoadjuvant Chemotherapy Response in Metaplastic Breast Cancer Patients
AI Summary

A retrospective cohort study evaluated the effectiveness of neoadjuvant chemotherapy in treating metaplastic breast cancer, a rare and aggressive form of the disease. The study found that 48% of patients who underwent chemotherapy achieved a pathologic complete response.

Why it matters

This research provides critical data on treatment outcomes for a rare cancer subtype, potentially informing future clinical protocols and the use of immunotherapy.

Dive DeeperCreate a free account to unlock

Background

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 95%

The content is a summary of clinical research findings presented in a professional medical context.

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in